Search research articles
Contact Us
Filters
Showing results (411-420 of 435) with videos related to
Page
of 44
Sort By:
NMR in Biomedicine
|
June 6, 2024
Indirect <sup>1</sup>H-[<sup>13</sup>C] MRS of the human brain at 7 T using a <sup>13</sup>C-birdcage coil and eight transmit-receive <sup>1</sup>H-dipole antennas with a 32-channel <sup>1</sup>H-receive array
Sarah M Jacobs, Jeanine J Prompers, Wybe J M van der Kemp, et al.
NMR in Biomedicine
|
April 9, 2025
Reproducibility of the Determination of <sup>13</sup>C-Labeling of Glutamate and Glutamine in the Human Brain Using selPOCE-MRS at 7 T Upon [U-<sup>13</sup>C]-Labeled Glucose Infusion
Narjes Ahmadian, Sarah M Jacobs, Mark Gosselink, et al.
Journal of Neurology
|
July 23, 2020
The neuro-otology of Susac syndrome
Todd A Hardy, Rachael L Taylor, Jessica Qiu, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
July 5, 2014
Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 3 treatment practicalities and recommendations. MS Neurology Group of the Australian and New Zealand Association of Neurologists
Simon A Broadley, Michael H Barnett, Mike Boggild, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
July 5, 2014
Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 1 historical and established therapies. MS Neurology Group of the Australian and New Zealand Association of Neurologists
Simon A Broadley, Michael H Barnett, Mike Boggild, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
July 3, 2014
Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 2 new and emerging therapies and their efficacy. MS Neurology Group of the Australian and New Zealand Association of Neurologists
Simon A Broadley, Michael H Barnett, Mike Boggild, et al.
The Journal of Clinical Investigation
|
December 7, 2023
PD-1H/VISTA mediates immune evasion in acute myeloid leukemia
Tae Kon Kim, Xue Han, Qianni Hu, et al.
The Medical Journal of Australia
|
July 31, 2015
A new era in the treatment of multiple sclerosis
Simon A Broadley, Michael H Barnett, Mike Boggild, et al.
Cancer
|
December 19, 2025
Characterization of chromosome 5 aberrations in TP53 mutated myeloid neoplasms with ≥5% blasts: An International TP53 Investigators Network (iTiN) study
Irfan Yasin, Anna Stengel, Haipeng Shao, et al.
Leukemia & Lymphoma
|
March 24, 2023
Myeloid sarcoma with <i>NPM1</i> mutation may be clinically and genetically distinct from AML with <i>NPM1</i> mutation: a study from the Bone Marrow Pathology Group
Maximiliano Ramia de Cap, Leo P Wu, Christian Hirt, et al.
Page
of 44
Search research articles
Search
Showing results (411-420 of 435) with videos related to
Sort By:
Page
of 44
NMR in Biomedicine
|
June 6, 2024
Indirect <sup>1</sup>H-[<sup>13</sup>C] MRS of the human brain at 7 T using a <sup>13</sup>C-birdcage coil and eight transmit-receive <sup>1</sup>H-dipole antennas with a 32-channel <sup>1</sup>H-receive array
Sarah M Jacobs, Jeanine J Prompers, Wybe J M van der Kemp, et al.
NMR in Biomedicine
|
April 9, 2025
Reproducibility of the Determination of <sup>13</sup>C-Labeling of Glutamate and Glutamine in the Human Brain Using selPOCE-MRS at 7 T Upon [U-<sup>13</sup>C]-Labeled Glucose Infusion
Narjes Ahmadian, Sarah M Jacobs, Mark Gosselink, et al.
Journal of Neurology
|
July 23, 2020
The neuro-otology of Susac syndrome
Todd A Hardy, Rachael L Taylor, Jessica Qiu, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
July 5, 2014
Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 3 treatment practicalities and recommendations. MS Neurology Group of the Australian and New Zealand Association of Neurologists
Simon A Broadley, Michael H Barnett, Mike Boggild, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
July 5, 2014
Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 1 historical and established therapies. MS Neurology Group of the Australian and New Zealand Association of Neurologists
Simon A Broadley, Michael H Barnett, Mike Boggild, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
July 3, 2014
Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 2 new and emerging therapies and their efficacy. MS Neurology Group of the Australian and New Zealand Association of Neurologists
Simon A Broadley, Michael H Barnett, Mike Boggild, et al.
The Journal of Clinical Investigation
|
December 7, 2023
PD-1H/VISTA mediates immune evasion in acute myeloid leukemia
Tae Kon Kim, Xue Han, Qianni Hu, et al.
The Medical Journal of Australia
|
July 31, 2015
A new era in the treatment of multiple sclerosis
Simon A Broadley, Michael H Barnett, Mike Boggild, et al.
Cancer
|
December 19, 2025
Characterization of chromosome 5 aberrations in TP53 mutated myeloid neoplasms with ≥5% blasts: An International TP53 Investigators Network (iTiN) study
Irfan Yasin, Anna Stengel, Haipeng Shao, et al.
Leukemia & Lymphoma
|
March 24, 2023
Myeloid sarcoma with <i>NPM1</i> mutation may be clinically and genetically distinct from AML with <i>NPM1</i> mutation: a study from the Bone Marrow Pathology Group
Maximiliano Ramia de Cap, Leo P Wu, Christian Hirt, et al.
Page
of 44